Evidence map›Paper›PMID 31147798›Full record

ArticleClinical rheumatology2019

Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis".

Francesco Caso, Loredana Postiglione, Bianca Covelli, Margherita Ricciardone, Gaetano Di Spigna, Pietro Formisano, Vittoria D'Esposito, Nicolò Girolimetto, Marco Tasso, Rosario Peluso and 9 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Observational
  8. A Bibliometric Analysis of Global Research Trends in Psoriasis and Metabolic Syndrome.Clinical, cosmetic and investigational dermatology · 2024
    Article
  9. Article
  10. Article
  11. JAK Inhibitors in Psoriatic Disease.Clinical, cosmetic and investigational dermatology · 2023
    Review
  12. Review
  13. Psoriatic arthritis from a mechanistic perspective.Nature reviews. Rheumatology · 2022
    Review
  14. Article
  15. Review
  16. Observational
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Francesco CasoRheumatology Unit, Department of Clinical Medicine and Surgery, School of Medicine, University Federico II of Naples, Via S. Pansini 5, 80131, Naples, Italy. francescocaso1@yahoo.it.ORCID http://orcid.org/0000-0002-8928-2520
Loredana PostiglioneTranslational Medical Sciences Department, School of Medicine, University Federico II of Naples, Naples, Italy.
Bianca CovelliTranslational Medical Sciences Department, School of Medicine, University Federico II of Naples, Naples, Italy.
Margherita RicciardoneTranslational Medical Sciences Department, School of Medicine, University Federico II of Naples, Naples, Italy.
Gaetano Di SpignaTranslational Medical Sciences Department, School of Medicine, University Federico II of Naples, Naples, Italy.
Pietro FormisanoTranslational Medical Sciences Department, School of Medicine, University Federico II of Naples, Naples, Italy.
Vittoria D'EspositoTranslational Medical Sciences Department, School of Medicine, University Federico II of Naples, Naples, Italy.
Nicolò GirolimettoRheumatology Unit, Department of Clinical Medicine and Surgery, School of Medicine, University Federico II of Naples, Via S. Pansini 5, 80131, Naples, Italy.
Marco TassoRheumatology Unit, Department of Clinical Medicine and Surgery, School of Medicine, University Federico II of Naples, Via S. Pansini 5, 80131, Naples, Italy.
Rosario PelusoRheumatology Unit, Department of Clinical Medicine and Surgery, School of Medicine, University Federico II of Naples, Via S. Pansini 5, 80131, Naples, Italy.
Luca NavariniUnit of Allergology, Clinical Immunology and Rheumatology, Università Campus Bio-Medico di Roma, Rome, Italy.
Massimo CiccozziUnit of Clinical Laboratory Science, Università Campus Bio-Medico di Roma, Rome, Italy.
Domenico Paolo Emanuele MargiottaUnit of Allergology, Clinical Immunology and Rheumatology, Università Campus Bio-Medico di Roma, Rome, Italy.
Francesca OlivieroDepartment of Clinical Medicine DIMED, University of Padova, Padua, Italy.
Antonella AfeltraUnit of Allergology, Clinical Immunology and Rheumatology, Università Campus Bio-Medico di Roma, Rome, Italy.
Leonardo PunziDepartment of Clinical Medicine DIMED, University of Padova, Padua, Italy.
Antonio Del PuenteRheumatology Unit, Department of Clinical Medicine and Surgery, School of Medicine, University Federico II of Naples, Via S. Pansini 5, 80131, Naples, Italy.
Raffaele ScarpaRheumatology Unit, Department of Clinical Medicine and Surgery, School of Medicine, University Federico II of Naples, Via S. Pansini 5, 80131, Naples, Italy.
Luisa CostaRheumatology Unit, Department of Clinical Medicine and Surgery, School of Medicine, University Federico II of Naples, Via S. Pansini 5, 80131, Naples, Italy.
Federico II University Hospital · ITUniversity of Naples Federico II · ITUniversità Campus Bio-Medico · ITUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAdipokines have been considered in the pathogenesis of the inflammatory processes of psoriatic arthritis (PsA). The main aim of the current study is to investigate possible differences and correlations between adipokines and clinical expression in PsA patients with and without clinical evident psoriasis.

methodsSerum levels of TNF-α, IL-6, leptin, resistin, visfatin, and ghrelin were measured in 80 consecutive PsA patients, 42 PsA patients with clinically evident psoriasis (group 1) and 38 PsA patients sine psoriasis (group 2), fulfilling the CASPAR criteria.

resultsPatients of the two groups were not significantly different for levels of TNF-α, IL-6, leptin, resistin, visfatin, and ghrelin. In the entire cohort, a positive association has been shown between leptin levels and female gender (β = 0.3, p = 0.001), BMI (β = 0.8, p < 0.0001), tender joint count (β = 0.23, p = 0.05), and patient pain-VAS score (β = 0.4, p = 0.049). In group 1, serum concentration of leptin was associated with female gender (β = 0.41, p < 0.0001) and BMI (β = 0.6, p = 0.012), whereas in group 2, a positive association was shown between leptin levels and BMI (β = 0.7, p = 0.003) and CRP (β = 0.35, p = 0.012). With regard to resistin, in the multivariate model, only the association between resistin and IL-6 was found (β = 0.33, p = 0.002). The association between resistin and IL-6 was confirmed in group 1 (β = 0.46, p = 0.004) but not in group 2.

conclusionsUntil today, the present study represents the first investigating difference in the adipokine pattern between PsA patients with psoriasis and sine psoriasis. We report a strict interplay between leptin, female gender, BMI, and inflammatory activity in overall PsA patients. In PsA patients with clinical evident psoriasis, leptin was associated with female gender and BMI, and a close association between resistin and IL-6 was found. Further, a positive association between leptin levels and BMI and CRP was found in PsA sine psoriasis patients. Further studies are also advocated for clarifying the possible role of these adipokines as laboratory findings or as disease mediators in addressing the different phenotypes of the disease. Key Points •Levels of TNF-α, IL-6, leptin, resistin, visfatin, and ghrelin did not differ between PsA patients with clinical evident psoriasis and PsA sine psoriasis. •There is a strict interplay between leptin, female gender, BMI, and inflammatory activity in PsA. •There is a close association between resistin and IL-6 in PsA patients with clinical evident psoriasis.

Indexed as

AdipokinesAdultArthritis, PsoriaticCross-Sectional StudiesFemaleGhrelinHumansInflammationInterleukin-6LeptinMaleMiddle AgedNicotinamide PhosphoribosyltransferasePsoriasisResistinSex FactorsAdipokinesGhrelinInterleukin-6LeptinNicotinamide PhosphoribosyltransferaseResistinRETN protein, humanTumor Necrosis Factor-alphaAdipokineBody mass indexLeptinPsA sine psoriasisPsoriatic arthritis

Identifiers

PMID31147798
OpenAlexW2947194102

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.